New milestone in the Horizon2020 project

We are happy to announce a new milestone in the Horizon2020 project: the first patient samples have arrived and are measured at the SkylineDx lab.
Read More

New MM treatment gains funding

5 October 2016 New MM treatment gains funding SkylineDx has received Horizon 2020 funding to develop a gene-expression profiling technology intended to predict treatment strategies for patients with multiple myeloma (MM). The announcement comes as SkylineDx prepares...
Read More

Project Partners

© MM Predict